NOX 1.52% 6.7¢ noxopharm limited

my guess is NOXCOVID has provided very limited or no convincing...

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    my guess is NOXCOVID has provided very limited or no convincing proof of efficacy to make it worth pursuing Covid further and will be quietly side lined//

    //anyway even if turned out there is something worth researching they’d be better off getting this into one of the big adaptive trials like “recovery”. Otherwise I don’t see anybody having appetite to conduct larger Covid trial with this drug.
    AIMO.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.